The World Health Organization-led program aims to buy antiviral Covid-19 pills for US$10. Meck & Co’s experimental pill molnupiravir is among the other drugs to be included to treat patients with mild symptoms.
WHO is ensuring that poorer countries get fair access to the vaccine shots, tests, and medications against the virus. It aims to secure antiviral drugs for these countries. Access to COVID-19 Tools Accelerator (ACT-A) is the document that outlines the goals till September next year. The ACT-A says that the program wishes to deliver 1 billion COVID-19 tests to the poorer countries and procure drugs to treat nearly 120 million out of 200 million patients worldwide. This data is estimated to be achieved in the next 12 months.
The organization wants to shore up supplies of drugs and test at a comparatively lower price. WHO has lost the vaccine race to wealthy nations who scooped up a huge share of the vaccine supply around the world which left the poorer countries with very few jabs available.
According to the officials, the draft is still under consultation and declined any comment before it is finalized. The estimate of the price of drugs, treatment, and tests will account for the program’s biggest expenses.